vs

Side-by-side financial comparison of Baxter International (BAX) and DILLARD'S, INC. (DDS). Click either name above to swap in a different company.

Baxter International is the larger business by last-quarter revenue ($2.7B vs $1.5B, roughly 1.8× DILLARD'S, INC.). DILLARD'S, INC. runs the higher net margin — 8.8% vs -0.6%, a 9.4% gap on every dollar of revenue. On growth, Baxter International posted the faster year-over-year revenue change (3.0% vs 2.9%). DILLARD'S, INC. produced more free cash flow last quarter ($156.2M vs $76.0M). Over the past eight quarters, Baxter International's revenue compounded faster (-15.8% CAGR vs -16.9%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

BAX vs DDS — Head-to-Head

Bigger by revenue
BAX
BAX
1.8× larger
BAX
$2.7B
$1.5B
DDS
Growing faster (revenue YoY)
BAX
BAX
+0.1% gap
BAX
3.0%
2.9%
DDS
Higher net margin
DDS
DDS
9.4% more per $
DDS
8.8%
-0.6%
BAX
More free cash flow
DDS
DDS
$80.2M more FCF
DDS
$156.2M
$76.0M
BAX
Faster 2-yr revenue CAGR
BAX
BAX
Annualised
BAX
-15.8%
-16.9%
DDS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
BAX
BAX
DDS
DDS
Revenue
$2.7B
$1.5B
Net Profit
$-15.0M
$129.8M
Gross Margin
33.0%
43.4%
Operating Margin
2.4%
11.5%
Net Margin
-0.6%
8.8%
Revenue YoY
3.0%
2.9%
Net Profit YoY
4.2%
EPS (diluted)
$-0.03
$8.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
DDS
DDS
Q1 26
$2.7B
Q4 25
$3.0B
$1.5B
Q3 25
$2.8B
$1.5B
Q2 25
$2.8B
$1.5B
Q1 25
$2.6B
$2.0B
Q4 24
$533.0M
$1.4B
Q3 24
$2.7B
$1.5B
Q2 24
$3.8B
$1.5B
Net Profit
BAX
BAX
DDS
DDS
Q1 26
$-15.0M
Q4 25
$-1.1B
$129.8M
Q3 25
$-46.0M
$72.8M
Q2 25
$91.0M
$163.8M
Q1 25
$126.0M
$214.4M
Q4 24
$-512.0M
$124.6M
Q3 24
$140.0M
$74.5M
Q2 24
$-314.0M
$180.0M
Gross Margin
BAX
BAX
DDS
DDS
Q1 26
33.0%
Q4 25
19.4%
43.4%
Q3 25
33.5%
36.6%
Q2 25
35.3%
43.9%
Q1 25
32.8%
34.9%
Q4 24
25.0%
42.6%
Q3 24
38.3%
37.6%
Q2 24
37.5%
44.6%
Operating Margin
BAX
BAX
DDS
DDS
Q1 26
2.4%
Q4 25
-24.5%
11.5%
Q3 25
6.1%
6.2%
Q2 25
6.8%
14.0%
Q1 25
2.2%
11.7%
Q4 24
-25.5%
11.4%
Q3 24
5.7%
6.5%
Q2 24
-5.0%
15.2%
Net Margin
BAX
BAX
DDS
DDS
Q1 26
-0.6%
Q4 25
-37.9%
8.8%
Q3 25
-1.6%
4.8%
Q2 25
3.2%
10.7%
Q1 25
4.8%
10.6%
Q4 24
-96.1%
8.7%
Q3 24
5.2%
5.0%
Q2 24
-8.2%
11.6%
EPS (diluted)
BAX
BAX
DDS
DDS
Q1 26
$-0.03
Q4 25
$-2.21
$8.31
Q3 25
$-0.09
$4.66
Q2 25
$0.18
$10.39
Q1 25
$0.25
$13.41
Q4 24
$-0.99
$7.73
Q3 24
$0.27
$4.59
Q2 24
$-0.62
$11.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
DDS
DDS
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.0B
Total Assets
$4.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
DDS
DDS
Q1 26
Q4 25
$2.0B
$1.1B
Q3 25
$1.7B
$1.0B
Q2 25
$1.7B
$900.5M
Q1 25
$2.3B
$717.9M
Q4 24
$1.8B
$980.4M
Q3 24
$1.4B
$946.7M
Q2 24
$2.1B
$817.8M
Total Debt
BAX
BAX
DDS
DDS
Q1 26
Q4 25
$9.5B
Q3 25
Q2 25
Q1 25
Q4 24
$10.4B
Q3 24
$10.4B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
DDS
DDS
Q1 26
Q4 25
$6.1B
$2.0B
Q3 25
$7.2B
$1.9B
Q2 25
$7.3B
$1.9B
Q1 25
$7.1B
$1.8B
Q4 24
$7.0B
$2.0B
Q3 24
$7.9B
$1.9B
Q2 24
$7.6B
$1.9B
Total Assets
BAX
BAX
DDS
DDS
Q1 26
Q4 25
$20.1B
$4.3B
Q3 25
$21.1B
$3.7B
Q2 25
$21.0B
$3.9B
Q1 25
$21.3B
$3.5B
Q4 24
$25.8B
$4.1B
Q3 24
$26.7B
$3.7B
Q2 24
$26.3B
$3.9B
Debt / Equity
BAX
BAX
DDS
DDS
Q1 26
Q4 25
1.55×
Q3 25
Q2 25
Q1 25
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
DDS
DDS
Operating Cash FlowLast quarter
$186.5M
Free Cash FlowOCF − Capex
$76.0M
$156.2M
FCF MarginFCF / Revenue
2.8%
10.6%
Capex IntensityCapex / Revenue
5.1%
2.1%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
DDS
DDS
Q1 26
Q4 25
$584.0M
$186.5M
Q3 25
$237.0M
$86.8M
Q2 25
$217.0M
$232.6M
Q1 25
$-193.0M
$364.7M
Q4 24
$488.0M
$173.5M
Q3 24
$253.0M
$-68.4M
Q2 24
$115.0M
$244.4M
Free Cash Flow
BAX
BAX
DDS
DDS
Q1 26
$76.0M
Q4 25
$156.2M
Q3 25
$60.1M
Q2 25
$215.8M
Q1 25
$349.3M
Q4 24
$145.4M
Q3 24
$-94.3M
Q2 24
$209.2M
FCF Margin
BAX
BAX
DDS
DDS
Q1 26
2.8%
Q4 25
10.6%
Q3 25
4.0%
Q2 25
14.1%
Q1 25
17.3%
Q4 24
10.2%
Q3 24
-6.3%
Q2 24
13.5%
Capex Intensity
BAX
BAX
DDS
DDS
Q1 26
5.1%
Q4 25
2.1%
Q3 25
1.8%
Q2 25
1.1%
Q1 25
0.8%
Q4 24
2.0%
Q3 24
1.7%
Q2 24
2.3%
Cash Conversion
BAX
BAX
DDS
DDS
Q1 26
Q4 25
1.44×
Q3 25
1.19×
Q2 25
2.38×
1.42×
Q1 25
-1.53×
1.70×
Q4 24
1.39×
Q3 24
1.81×
-0.92×
Q2 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons